Skip to content

Library

View the latest content of the Tumour Models London Summit and other PREDiCT Events

3D Cell-Based Assays for Drug Screens Challenges in Imagine, Image Analysis, and High-Content Analysis Image

An exclusive paper by:

Tijmen H. Booij,
Leo S. Price &
Erik H. J. Danen

Leidenburg University & OCellO

Join Gabri Van Der Pluijm, Leiden University, for his talk on:

  • ‘Near-Patient’ Models for the Assessment of Individualised Drug Responses in Urological Malignancies
TML Speaker Interview Crown Bioscience thumbnail

An exclusive interview with:

Ludovic Bourré
Expert Speaker, PREDiCT: Tumour Models London

Senior Director Scientific Engagement,
Crown Bioscience

Join Ludovic for his sessions on:

  • "Tumour Microenvironment, Heterogeneity & Clinically Relevant Models"
  • "Panel Discussion – Industry Insight: How to Utilise Complimentary Models to Drive Drug Discovery Development"
  • "MATCH-R, Development of Preclinical Models from Patients with Acquired Resistance to Targeted Therapy"
TML Stemonix Speaker Interview thumbnail

An exclusive interview with:

Fabian Zanella
Expert Speaker, PREDiCT: 3D Tissue Models 2019

Director of R&D,
StemoniX

Paul McSheely Speaker Insight Basilea Pharmaceutica

60 seconds with:

Paul McSheehy
Expert Speaker, PREDiCT: Tumour Models London

Senior Scientist & Leader - Cancer Biology In Vivo & Translational Science Oncology,
Basilea Pharmaceutica

Join Paul for his sessions on"Preclinical Profiling of Derazantinib (BAL087), an FGF-R Inhibitor Currently in Phase-2 Clinical Trials"  and "Industry Insight: How to Utilise Complimentary Models to Drive Drug Discovery Development"

hitesh mistry interview

60 seconds with:

Hitesh Mistry
Expert Speaker, PREDiCT: Tumour Models London

Clinical Pharmacometrics, Biostatistics, Data Science Senior Research Fellow,
University of Manchester

Join Hitesh for his session on"Curious Preclinical-Clinical Correlations of Marketed IO Therapies"

content snippet 3

An exclusive interview with:

Anna Bunin
Expert Speaker, PREDiCT: Tumor Models Boston
Associate Director - Immunology, KleoPharmaceuticals Inc.

content snippet 4

An exclusive interview with:

Davy Ouyang
Expert Speaker, PREDiCT: Tumor Models Boston
Executive Director, Cancer Pharmacology, Crown Bioscience

content snippet 5

Past presentation:

Challenges, Insights, and Future Directions for Experimental Models in Cancer Immunotherapy

Dr Shiva Kazerounian
Expert Speaker, PREDiCT: Tumor Models Boston
Principal Scientist, In Vivo Pharmacology Lead, Berg Pharma

content snippet 1

Past presentation:

FDA Perspectives on Organs and Tissues on a Chip

 

Suzanne Fitzpatrick, Ph.D
Expert Speaker, PREDiCT: 3D Tissue Models
Senior Advisor for Toxicology Center for Food Safety and Applied Nutrition, US Food and Drug Administration (FDA)

content snippet 2

Past presentation:

Incorporation Improved Physiological Relevant in Tox21: an Evolution of Resolution

 

Stephen S. Ferguson, Ph.D.
Expert Speaker, PREDiCT: 3D Tissue Models
National Toxicology Program Division, National Institute of Environmental Health Sciences